Thinking of joining a study?

Register your interest

NCT06397677 | RECRUITING | Rheumatoid Arthritis


Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Sponsor:

University of Colorado, Denver

Brief Summary:

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Condition or disease

Rheumatoid Arthritis

Interstitial Lung Disease

Intervention/treatment

Research Testing Performed (Laboratory)

Information Collected as Standard of Care

Research Testing Performed

Detailed Description:

The central hypothesis is that novel quantitative imaging and specific blood markers will be associated with progressive RA-ILD. The hypothesis will be tested through collection and analysis of peripheral blood, in addition to the analysis of HRCT (high-resolution computed tomography) scans performed as standard of care (clinical) on research subjects. Procedures performed: Baseline Year 0: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs Every 4 months (at clinic visit): Blood sample, questionnaires Year 1 and Year 2 Follow-ups: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs

Study Type : OBSERVATIONAL
Estimated Enrollment : 450 participants
Official Title : Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)
Actual Study Start Date : 2024-01-22
Estimated Primary Completion Date : 2029-01
Estimated Study Completion Date : 2034-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 90 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
  • * 18 years of age or older
Exclusion Criteria
  • * Prior medication treatment specifically for RA-ILD
  • * Inability to give informed consent
  • * Pregnant women

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

Location Details

NCT06397677


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, California

University of California San Francisco

San Francisco, California, United States, 94143

RECRUITING

United States, Colorado

University of Colorado Denver

Aurora, Colorado, United States, 80045

RECRUITING

United States, Kansas

University of Kansas

Kansas City, Kansas, United States, 66103

RECRUITING

United States, Michigan

University of Michigan

Ann Arbor, Michigan, United States, 48109

Loading...